These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 6400950)

  • 1. [Neurologic status and changes in the cerebrospinal fluid of patients with complete ischemic cerebrovascular insult before and after therapy with Redergin].
    Panić M; Mrsulja BB; Micić D; Sinanović O; Dilber S; Hudić J; Mulić H
    Med Arh; 1984; 38(2):73-81. PubMed ID: 6400950
    [No Abstract]   [Full Text] [Related]  

  • 2. [Therapeutic effectiveness and safety of dihydroergocristine. A study of 9,702 patients].
    Mailland F; Zottino G
    Fortschr Med; 1986 Mar; 104(11):239-42. PubMed ID: 3084366
    [No Abstract]   [Full Text] [Related]  

  • 3. [Serum and cerebrospinal fluid enzymatic activity in diseases of the nervous system (II). Cerebrovascular ischemic accidents].
    Martínez M; Vilches JJ; González A; Benedito J; Sala J; Villarroya T
    Rev Clin Esp; 1979 Jul 15-31; 154(1-2):23-6. PubMed ID: 534293
    [No Abstract]   [Full Text] [Related]  

  • 4. [Evaluation of the effectiveness of dihydroergotoxine (DHET) in the treatment of chronic cerebral ischemia syndromes in elderly patients].
    Derejczyk J; Panuś K
    Wiad Lek; 1986 Jun; 39(12):818-24. PubMed ID: 3535261
    [No Abstract]   [Full Text] [Related]  

  • 5. [Trials in the treatment of cerebrovascular insufficiency with the monodrug dihydroergocristine. A multicentric study].
    Finke J; Haehn KD; Haase W
    Med Welt; 1982 Jul; 33(28):1042-7. PubMed ID: 6811832
    [No Abstract]   [Full Text] [Related]  

  • 6. [Vasobral and stabilized cerebral vascular complication: hemodynamic and psychometric study].
    Poncin-Lafitte M; Migeon P; Rancurel G; Rapin JR
    Ann Radiol (Paris); 1987; 30(6):425-30. PubMed ID: 3129979
    [No Abstract]   [Full Text] [Related]  

  • 7. [Use of redergin in patients with vertebrobasilar syndrome].
    Pashchuk AIu; Kudimov SA; Kotul'skiĭ IV; Gruntovskiĭ GKh
    Ortop Travmatol Protez; 1983 Dec; (12):25-8. PubMed ID: 6142444
    [No Abstract]   [Full Text] [Related]  

  • 8. [Changes in leucine-enkephalin concentrations in the lumbar cerebrospinal fluid from patients with ischemic cerebrovascular disease].
    Liu DK
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1988 Feb; 21(1):1-2, 61. PubMed ID: 3402267
    [No Abstract]   [Full Text] [Related]  

  • 9. Superoxide dismutase and lipid peroxidation in cerebrospinal fluid of patients with ischemic brain stroke.
    Sonecki P; Olczyk K; Gralewski Z; Ogrodowska-Hamankiewicz E
    Acta Biochim Pol; 1994; 41(2):148-50. PubMed ID: 7976028
    [No Abstract]   [Full Text] [Related]  

  • 10. [Review of certain antagonists of peroxidation of membrane lipids by free radicals in the therapy of acute cerebrovascular accidents of ischemic origin].
    Cahn J; Borzeix MG; Akimjak JP; Angignard J; Labos M; Lebeau M
    Agressologie; 1982; 23(C):21-9. PubMed ID: 6812445
    [No Abstract]   [Full Text] [Related]  

  • 11. Fibrinogen degradation products in serum and cerebrospinal fluid in cerebrovascular diseases.
    Nowacki P; Stańkowska-Chomicz A; Borodin M
    Neuropatol Pol; 1990; 28(3-4):257-60. PubMed ID: 2097553
    [No Abstract]   [Full Text] [Related]  

  • 12. Tau protein in the cerebrospinal fluid is a marker of brain injury after aortic surgery.
    Shiiya N; Kunihara T; Miyatake T; Matsuzaki K; Yasuda K
    Ann Thorac Surg; 2004 Jun; 77(6):2034-8. PubMed ID: 15172260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Occurrence of nervous system involvement in SIRS.
    Marchiori PE; Lino AM; Hirata MT; Carvalho NB; Brotto MW; Scaff M
    J Neurol Sci; 2006 Dec; 250(1-2):147-52. PubMed ID: 17028030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombolysis in patients with marked clinical fluctuations in neurologic status due to cerebral ischemia.
    Ozdemir O; Beletsky V; Chan R; Hachinski V
    Arch Neurol; 2008 Aug; 65(8):1041-3. PubMed ID: 18695054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Epileptic manifestations in cerebrovascular patients--acid-base values in arterial blood and cerebrospinal fluid].
    Kovacević MS; Kostić VS; Rakić G
    Srp Arh Celok Lek; 1984 Jun; 112(6):695-702. PubMed ID: 6523256
    [No Abstract]   [Full Text] [Related]  

  • 16. [Electrophoresis of cerebrospinal fluid proteins in patients with ischemic cerebrovascular disease].
    Fernández-Carriera RA; González-Quevedo A; Lara-Rodríguez RF; León-Ortiz MM; González-García S; Vicente-Valdés I
    Rev Neurol; 2002 Nov 16-30; 35(10):908-12. PubMed ID: 12436394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the bioavailability of Redergin tablets (1.0 mg) and Redergin solution.
    Kopitar Z; Milovac J; Vrhovac B; Tadjer I
    Int J Clin Pharmacol Ther Toxicol; 1982 Mar; 20(3):134-8. PubMed ID: 7068286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pathogenetic significance of patent foramen ovale in patients with the determined cause of ischemic insult].
    Suslina ZA; Foniakin AV; Glebov MV; Geraskina LA; Chechetkin AO; Kravchenko MA
    Klin Med (Mosk); 2009; 87(4):14-8. PubMed ID: 19514314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Acid-base equilibrium of the cerebrospinal fluid in increased intracranial pressure].
    Mrówka R
    Psychiatr Neurol Med Psychol (Leipz); 1980 May; 32(5):281-9. PubMed ID: 7413861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel surrogate markers for acute brain damage: cerebrospinal fluid levels corrrelate with severity of ischemic neurodegeneration in the rat.
    Siman R; Zhang C; Roberts VL; Pitts-Kiefer A; Neumar RW
    J Cereb Blood Flow Metab; 2005 Nov; 25(11):1433-44. PubMed ID: 15902199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.